Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8648 | 1163 | 43.2 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1498 | 7016 | ADVANCED GLYCATION END PRODUCTS//HMGB1//RAGE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RAGE | Author keyword | 94 | 33% | 20% | 237 |
2 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | Author keyword | 89 | 52% | 10% | 120 |
3 | SRAGE | Author keyword | 82 | 68% | 6% | 73 |
4 | SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | Author keyword | 59 | 81% | 3% | 35 |
5 | SOLUBLE RAGE | Author keyword | 29 | 73% | 2% | 22 |
6 | ESRAGE | Author keyword | 28 | 81% | 1% | 17 |
7 | BIOCHEM MOL VASC BIOL | Address | 28 | 51% | 3% | 39 |
8 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS RAGE | Author keyword | 18 | 48% | 2% | 27 |
9 | ENDOGENOUS SECRETORY RAGE | Author keyword | 15 | 88% | 1% | 7 |
10 | RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS | Author keyword | 11 | 47% | 1% | 17 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RAGE | 135 | 34% | 28% | 323 |
2 | SOLUBLE RECEPTOR | 95 | 37% | 17% | 203 |
3 | SRAGE | 82 | 86% | 4% | 42 |
4 | GLY82SER POLYMORPHISM | 57 | 95% | 2% | 19 |
5 | ENDPRODUCTS RAGE | 54 | 80% | 3% | 33 |
6 | ENDOGENOUS SECRETORY RAGE | 52 | 82% | 3% | 31 |
7 | RAGE GENE | 47 | 69% | 3% | 40 |
8 | ENDOGENOUS SECRETORY RECEPTOR | 46 | 82% | 2% | 27 |
9 | DECREASED RENAL FUNCTION | 38 | 93% | 1% | 14 |
10 | G82S POLYMORPHISM | 37 | 100% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cellular signalling of the receptor for advanced glycation end products (RAGE) | 2013 | 44 | 180 | 52% |
The RAGE Axis A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature | 2010 | 120 | 84 | 54% |
Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond | 2013 | 24 | 64 | 63% |
Understanding RAGE, the receptor for advanced glycation end products | 2005 | 498 | 87 | 48% |
Unlocking the biology of RAGE in diabetic microvascular complications | 2014 | 20 | 81 | 26% |
RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts | 2009 | 97 | 76 | 67% |
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications | 2009 | 113 | 98 | 56% |
The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes | 2012 | 37 | 69 | 58% |
RAGE in tissue homeostasis, repair and regeneration | 2013 | 30 | 115 | 43% |
Soluble forms of RAGE in internal medicine | 2009 | 58 | 64 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOCHEM MOL VASC BIOL | 28 | 51% | 3.4% | 39 |
2 | DIABET PROGRAM ENDOCRINOL | 5 | 63% | 0.4% | 5 |
3 | MED CLIN CHEM 1 | 4 | 18% | 1.6% | 19 |
4 | INTER MOL MED CIRMC | 3 | 39% | 0.6% | 7 |
5 | VASC AGING BIOL | 3 | 60% | 0.3% | 3 |
6 | BIOL VASC CELLULAIRE | 3 | 35% | 0.5% | 6 |
7 | BLOOD VESSEL INTER E VASC REPAIR UNIT | 2 | 67% | 0.2% | 2 |
8 | EA 1557 | 2 | 67% | 0.2% | 2 |
9 | HANGZHOU HOSP 1 | 2 | 67% | 0.2% | 2 |
10 | IST CITTA PAVIA | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000250201 | ADVANCED GLYCATION END PRODUCTS//GLYCATION//PENTOSIDINE |
2 | 0.0000235585 | HMGB1//HIGH MOBILITY GROUP BOX 1//HIGH MOBILITY GROUP BOX 1 PROTEIN |
3 | 0.0000114682 | S100A4//S100A9//S100A2 |
4 | 0.0000036752 | S 100B//S 100B PROTEIN//NEURON SPECIFIC ENOLASE |
5 | 0.0000036669 | METHYLGLYOXAL//GLYOXALASE I//GLYOXALASE |
6 | 0.0000033127 | METABOLIC MEMORY//HYPERGLYCEMIC MEMORY//EPIGEN PROFILING IL |
7 | 0.0000026366 | ESTUDOS EST SE OXIDAT 32//MITOCHONDRIAL ELECTRON TRANSFER CHAIN//ESTUDOS EST SE OXIDATIVO |
8 | 0.0000025436 | SALIVARY GLUCOSE//TISSUE MORPHOL//CONTROL OF DIABETES |
9 | 0.0000023977 | TUMOR NECROSIS FACTOR CONVERTING ENZYME//KINSMEN NEUROL//FIBRILLAR PLAQUE |
10 | 0.0000021361 | CEREBRAL AMYLOID ANGIOPATHY//CEREBRAL MICROBLEEDS//MICROBLEEDS |